Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Autolus Therapeutics plc changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 89 | 1 | 84 | −4 |
| Shares | 139.3M | 26.9K | 134.4M | −4.88M (−3.5%) |
| Value | $277.1M | $53.5K | $184.4M | −$92.6M (−33.4%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Autolus Therapeutics plc at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 971,691 | $1.34M | 0.00% |
| Marex Group plc | 542,857 | $749.1K | 0.01% |
| Millennium Management LLC | 204,728 | $282.5K | 0.00% |
| Aquatic Capital Management LLC | 114,398 | $157.9K | 0.00% |
| Warren Averett Asset Management, LLC | 26,870 | $37.1K | 0.00% |
| Apollon Wealth Management, LLC | 14,003 | $19.3K | 0.00% |
| Claro Advisors LLC | 12,500 | $17.3K | 0.00% |
| QRG Capital Management, Inc. | 10,925 | $15.1K | 0.00% |
| Barclays PLC | 8,074 | $11.1K | 0.00% |
Sold out (13)
Institutions that held Autolus Therapeutics plc at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| HealthInvest Partners AB | 1,169,634 | $2.33M |
| Arizona PSPRS Trust | 150,000 | $298.5K |
| Gsa Capital Partners LLP | 119,546 | $238.0K |
| OpenArc Corporate Advisory, LLC | 84,850 | $168.9K |
| Avanza Fonder AB | 53,522 | $106.5K |
| Scientech Research LLC | 48,572 | $96.7K |
| Federation des caisses Desjardins du Quebec | 31,328 | $62.3K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 30,095 | $59.9K |
| Royal Bank of Canada | 10,000 | $20.0K |
| Garton & Associates Financial Advisors LLC | 600 | $1.19K |
| Daiwa Securities Group Inc. | 575 | $1.00K |
| EverSource Wealth Advisors, LLC | 163 | $324 |
| SageView Advisory Group, LLC | 75 | $150 |
Not filed for Q1 2026 yet (1)
Institutions that held Autolus Therapeutics plc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Forefront Wealth Management Inc. | 26,870 | $53.5K |